Search - tctmd.com

Displaying 21 - 40 of 61

Sort: Relevancy | Date

Presentation Cardiovascular Interventions 2018

PFO Closure to Prevent Recurrent Cryptogenic Stroke

Presenter: Matthew J. Price

October 26, 2018

News Daily News

Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks

Todd Neale

August 13, 2018

News Daily News

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

L.A. McKeown

May 16, 2018

Podcast TCTMD Talking Points

Episode 25: RESPECT - Final Long-term Outcomes of PFO Closure for Cryptogenic Stroke

July 12, 2017

News Daily News

Two New Trials Buoy Outlook for PFO Closure in Patients With Cryptogenic Stroke

Todd Neale

May 24, 2017

Presentation SIF 2017

PFO Closure for Cryptogenic Stroke Choose your Patients Well

Presenter: James A. Goldstein

March 09, 2017

News Daily News

PFO and Migraine? New Study Zeros in on Atrial Septal Aneurysms

Shelley Wood

December 08, 2016

News Industry News TCT 2016

Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

November 01, 2016

News Conference News TCT 2016

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Yael L. Maxwell

November 01, 2016

Presentation TCT 2016

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

Presenter: Howard C. Herrmann, Robert J. de Winter, David E. Thaler

November 01, 2016

News Daily News

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

Yael L. Maxwell

October 28, 2016

News Industry News

Medtronic Announces Approval and Launch of Reveal LINQ(TM) Insertable Cardiac Monitor in Japan

September 14, 2016

News Daily News

New PFO Guidelines: No Routine Offer of Closure for Cryptogenic Stroke, Says American Academy of Neurology

Shelley Wood

July 27, 2016

Presentation TVT 2016

What Do I Do With a Patient With Cryptogenic Stroke?

Presenter: Creighton W. Don

June 18, 2016

News Daily News

Majority of FDA Advisors Give Green Light to Amplatzer PFO Closure Device for Stroke

Shelley Wood

May 25, 2016

News Industry News

Real-World Study Shows 72 Percent of Atrial Fibrillation Would Have Gone Undiagnosed in Stroke Patients if Cardiac Monitoring Had Been Limited to 30 Days

April 20, 2016

News Industry News

Stroke Prevention: BIOTRONIK Announces FDA Approval of BioMonitor 2 Insertable Cardiac Monitor

April 12, 2016

News Daily News

PFO Closure Faces Renewed Scrutiny in Patient-Level Meta-Analysis

Yael L. Maxwell

February 22, 2016

News Features

Interventionalist vs Neurologist: RESPECT for Both Sides of the PFO Closure Debate

Yael L. Maxwell

November 01, 2015

News Conference News TCT 2015

RESPECT Confirms Long-term Safety, Efficacy of PFO Closure for Recurrent Stroke

Nicole Lou

October 15, 2015

Advertisement

PFO Closure to Prevent Recurrent Cryptogenic Stroke

Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

Episode 25: RESPECT - Final Long-term Outcomes of PFO Closure for Cryptogenic Stroke

Two New Trials Buoy Outlook for PFO Closure in Patients With Cryptogenic Stroke

PFO Closure for Cryptogenic Stroke Choose your Patients Well

PFO and Migraine? New Study Zeros in on Atrial Septal Aneurysms

Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

Medtronic Announces Approval and Launch of Reveal LINQ(TM) Insertable Cardiac Monitor in Japan

New PFO Guidelines: No Routine Offer of Closure for Cryptogenic Stroke, Says American Academy of Neurology

What Do I Do With a Patient With Cryptogenic Stroke?

Majority of FDA Advisors Give Green Light to Amplatzer PFO Closure Device for Stroke

Real-World Study Shows 72 Percent of Atrial Fibrillation Would Have Gone Undiagnosed in Stroke Patients if Cardiac Monitoring Had Been Limited to 30 Days

Stroke Prevention: BIOTRONIK Announces FDA Approval of BioMonitor 2 Insertable Cardiac Monitor

PFO Closure Faces Renewed Scrutiny in Patient-Level Meta-Analysis

Interventionalist vs Neurologist: RESPECT for Both Sides of the PFO Closure Debate

RESPECT Confirms Long-term Safety, Efficacy of PFO Closure for Recurrent Stroke

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content